NCT02246907

Brief Summary

The purpose of this study is to evaluate the impact of an exercise intervention on patient-reported anxiety, depression, fatigue, and sleep disturbances among acute leukemia patients. The investigators hypothesize that exercise will reduce fatigue in acute leukemia patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2014

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 23, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

November 23, 2016

Status Verified

November 1, 2016

Enrollment Period

1.8 years

First QC Date

March 27, 2014

Last Update Submit

November 22, 2016

Conditions

Keywords

Health related quality of life

Outcome Measures

Primary Outcomes (1)

  • Compare symptoms of fatigue in newly diagnosed acute leukemia patients

    Symptoms will be assessed by patient reported survey at baseline, weekly through patient hospitalization, and then again at patient's first appointment after hospital discharge. We are interested in how the symptom changes over time.

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

Secondary Outcomes (9)

  • Evaluate health-related quality of life changes over time

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Compare symptoms of anxiety between groups

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Compare symptoms of depression between groups

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Compare sleep quality between groups

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • Changes in cardiovascular function

    participants will be followed for the duration of hospital stay, an expected average of 6 weeks

  • +4 more secondary outcomes

Study Arms (2)

Control Group

NO INTERVENTION

The control group will receive standard of care which includes recreational therapy and standard encouragement.

Exercise

OTHER

Participants in this arm will receive standard of care plus exercise for the duration of their inpatient stay for induction chemotherapy.

Other: Exercise

Interventions

All intervention patients will participate in an individualized prescriptive exercise intervention 2 to 4 times per week for a period of the induction chemotherapy/in-hospital recovery. The exercise intervention will begin on week 1 of the study, the day after the first batteries of initial assessments are concluded. Each exercise session will be divided into two parts. One part will be administered in the morning and the second one late in the afternoon. There will be a period of rest of at least 36 hours between each exercise session.

Also known as: Exercise and Quality of Life in Acute Leukemia Patients
Exercise

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed with acute leukemia by pathology report
  • Admitted for induction chemotherapy within in the previous 96 hours or +/- 3 days from initiation of induction chemotherapy
  • An expected hospital stay of 3-4 weeks or longer
  • Participation in the study must be approved by the physician directly responsible for the patient's care while at University of North Carolina -Hospitals
  • Age \>21 years of age
  • Willing and able to provide, signed informed consent
  • Willing and able to use a computer to complete study questionnaires
  • Ability to understand and speak English

You may not qualify if:

  • Cardiovascular disease (unless the disease would not compromise the patient's ability to participate in the exercise rehabilitation program)
  • Acute or chronic respiratory disease that would compromise the patient's ability to participate in the exercise rehabilitation program
  • Acute or chronic bone, joint, or muscular abnormalities that would compromise the patient's ability to participate in the exercise rehabilitation program
  • Inability to understand and speak English
  • Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent
  • Another active malignancy
  • Patients will also be excluded if they have active bleeding, acute thrombosis, ischemia, hemodynamically unstable, and uncontrolled pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina Lineberger Comprehenisive Cancer Center

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Interventions

ExerciseQuality of Life

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Officials

  • Ashley Bryant, PhD, RN

    UNC- Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Claudio Battaglini, PhD

    UNC- Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2014

First Posted

September 23, 2014

Study Start

January 1, 2014

Primary Completion

November 1, 2015

Study Completion

December 1, 2015

Last Updated

November 23, 2016

Record last verified: 2016-11

Locations